188 related articles for article (PubMed ID: 11844808)
1. An evolving role for oral fluoropyrimidine drugs.
Diasio RB
J Clin Oncol; 2002 Feb; 20(4):894-6. PubMed ID: 11844808
[No Abstract] [Full Text] [Related]
2. New drugs in therapy of colorectal cancer: preclinical studies.
Rustum YM; Cao S
Semin Oncol; 1999 Dec; 26(6):612-20. PubMed ID: 10606254
[TBL] [Abstract][Full Text] [Related]
3. Contemporary issues and the potential uses of capecitabine in metastatic breast cancer.
Barrett-Lee P; Bidard FC; Pierga JY
Cancer Treat Rev; 2009 Nov; 35(7):582-9. PubMed ID: 19632050
[TBL] [Abstract][Full Text] [Related]
4. Oral 5-FU analogues in the treatment of breast cancer.
Bunnell CA; Winer EP
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):39-43. PubMed ID: 9830624
[TBL] [Abstract][Full Text] [Related]
5. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
Cunningham D; Coleman R
Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
Aprile G; Mazzer M; Moroso S; Puglisi F
Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine: fulfilling the promise of oral chemotherapy.
Hwang JJ; Marshall JL
Expert Opin Pharmacother; 2002 Jun; 3(6):733-43. PubMed ID: 12036413
[TBL] [Abstract][Full Text] [Related]
8. Novel oral chemotherapy agents.
Royce ME; Hoff PM; Pazdur R
Curr Oncol Rep; 2000 Jan; 2(1):31-7. PubMed ID: 11122822
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine in gastric cancer.
Okines A; Chau I; Cunningham D
Drugs Today (Barc); 2008 Aug; 44(8):629-40. PubMed ID: 18846273
[TBL] [Abstract][Full Text] [Related]
10. [Fluorinated pyrimidines in oral treatment of advanced colorectal cancer].
Todnem K; Harboe K; Zotova L; Lind A; Ogreid D
Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2781-5. PubMed ID: 11107924
[TBL] [Abstract][Full Text] [Related]
11. The clinical pharmacology of the oral fluoropyrimidines.
Takimoto CH
Curr Probl Cancer; 2001; 25(3):134-213. PubMed ID: 11408845
[No Abstract] [Full Text] [Related]
12. Oral capecitabine (Xeloda) in cancer treatment.
Doyle DP; Engelking C
Nurse Pract; 2007 Feb; 32(2):18-21. PubMed ID: 17264789
[No Abstract] [Full Text] [Related]
13. [The potential of capecitabine (Xeloda) in the treatment of disseminated solid tumors].
Moiseenko VM; Semenova AI; Orlova RV
Vopr Onkol; 2001; 47(1):112-9. PubMed ID: 11317529
[No Abstract] [Full Text] [Related]
14. Nursing considerations for capecitabine-based combination therapy.
Becze E
ONS Connect; 2009 Apr; 24(4):14-5. PubMed ID: 19413236
[No Abstract] [Full Text] [Related]
15. Oral fluoropoyrimidines.
Hoff PM; Royce M; Medgyesy D; Brito R; Pazdur R
Semin Oncol; 1999 Dec; 26(6):640-6. PubMed ID: 10606257
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer.
Cassata A; Procoplo G; Alù M; Ferrari L; Ferrario E; Beretta E; Longarini R; Busto G; De Candis D; Bajetta E
Tumori; 2001; 87(6):364-71. PubMed ID: 11989587
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced disease and new drugs.
Frustaci S; Buonadonna A; La Mura N; Berretta M; De Paoli A
Suppl Tumori; 2003; 2(5):S48-50. PubMed ID: 12914391
[No Abstract] [Full Text] [Related]
18. Targeted therapy for metastatic breast cancer.
Muss HB
N Engl J Med; 2006 Dec; 355(26):2783-5. PubMed ID: 17192546
[No Abstract] [Full Text] [Related]
19. [New therapeutic prospects with capecitabin in breast carcinoma].
Venturini M; Catzeddu T
Tumori; 2002; 88(1):A1-6. PubMed ID: 12008671
[No Abstract] [Full Text] [Related]
20. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
Iqbal S; Lenz HJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]